Kimberly-Clark takes the lead in hand hygiene compliance
Improving hand hygiene compliance has been identified by the World Health Organisation as one of the key strategies to reduce Hospital Associated Infections (HAIs) globally. Australian hospitals are now mandated to conduct ongoing audits and submit the results to Hand Hygiene Australia – which can be a timely and labour-intensive exercise for any already time-constrained hospital department.
iCombat HAIs is a brand new paperless, mobile audit application that has been designed, according to the World Health Organisation’s 5 Moments for Hand Hygiene, to make compulsory hand hygiene audits easier, quicker and more effective for hospitals. It increases the speed of data collection and collation, whilst dramatically cutting data processing time. Furthermore, iCombat HAIs is coupled with a powerful enterprise information portal (EiP), a real-time evidence-based decision support platform.
Hospitals globally are now running intervention programs on a daily basis – this has seen dramatic improvements in hand hygiene compliance, while at the same time reducing the incidence of Hospital Associated Infections. iCombat HAIs tracks these interventions and their performance, those yielding better hand hygiene outcomes can now be quantified ed and reported on.
The unique EiP provides users with a secure unified access point to store, collate and aggregate a database of hand hygiene compliance and intervention outcomes. Maintained by an independent and trusted third party, giving you peace of mind that your data will be securely managed whilst complying with the strictest privacy regulations.
Kimberly-Clark is committed to reducing the incidence of HAIs by providing products, tools, and educational services to health care workers on the frontline. iCombat HAIs complements this suite of products and educational services to increase hand hygiene compliance and decrease the incidence of HAIs.
If you require further information on the iCombat HAIs application or if you would like to run a trial using the iCombat HAI’s and the Enterprise Information Portal (EiP) please contact:
Anesh Naidoo, Market Segment Manager
Phone: +612 9963 8682
Each drug in the combination has a different mechanism of action to kill myeloma cells, and all...
A vaccine expert has dashed hopes of an adenovirus vector-based COVID-19 vaccine coming to market...
A team of researchers at The University of Queensland may have found a way to improve treatment...